$0.1963
0.00945.03%
Ult. Agg.: Nov 6, 6:48 PM
20/20 Biolabs (AIDX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.26 | $-0.12 | -116.7 % |
| Q1 | May 20, 2026 | $-0.28 | $-0.10 | -180.0 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $730.57K | $636.00K | 14.9 % |
| Q1 | May 20, 2026 | $353.38K | $779.00K | -54.6 % |
| Metric | Q2 '26 | Q1 '26 | FY '25 |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Estimate | $-0.12 | $-0.10 | — |
| Actual | $-0.26 | $-0.28 | $-0.76 |
| Surprise | -116.7% | -180.0% | — |
| Revenue | |||
| Estimate | $636000 | $779000 | — |
| Actual | $730571 | $353375 | $2.0M |
| Surprise | +14.9% | -54.6% | — |
| Metric | Q3 '26E | FY '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.06 | $-0.42 |
| Revenue | ||
| Consensus | $891000 | $2.9M |